get a key
steadybase-$ company TECH
account_id none on file
legal_name BIO-TECHNE Corp
ticker TECH
cik 842023
domain bio-techne.com
entry_point_account_id none on file
name Bio-Techne Corp
exchange Nasdaq
sector Health Care
hq Minneapolis, MN, United States
calls 12 filings 60 executives 12 family 0
why_nownone on file
calls
The operating leverage reflects the benefits of structural streamlining and disciplined expense management, partially offset by targeted investments and strategic growth initiatives.

Feb 4, 2026 / receipt, needs a key / Jim Hippel, CFO | earnings call 2026-02-04 | transcript 7ab75bbc-9adc-4a47-acee-ed6f5b445ccb | chars 16653-16835 | segment 16

This consistency reflects the benefits of structural streamlining and disciplined expense management partially offset by targeted investments and strategic growth initiatives.

Nov 5, 2025 / receipt, needs a key / Jim Hippel, CFO | earnings call 2025-11-05 | transcript c5703122-c07a-4b00-92da-57080056fa3f | chars 16073-16248 | segment 16

The decrease in relative SG&A and R&D was driven by operational efficiencies and diligent expense management, which was partially offset by ongoing strategic growth investments.

Aug 8, 2023 / receipt, needs a key / Jim Hippel, CFO | earnings call 2023-08-08 | transcript ba0d8520-cb61-45c1-bb34-64eb048af0ba | chars 20731-20908 | segment 19

It seemed like everyone was on vacation in July and August, perhaps making up for the prior two COVID years when travel was more restricted.

Nov 1, 2022 / receipt, needs a key / Chuck Cometh, CEO | earnings call 2022-11-01 | transcript 1532f222-34c5-423d-97d4-ab1e0a37ca0f | chars 4945-5085 | segment 4

Yeah, sure. Um, I mean, we finished the quarter very strong, and as we've mentioned in the past, we haven't seen too much degradation in any of our markets. We finished in the U.S. biopharma around 30% growth, and academia keeps trickling north. Now we're near high single-digit growth for the quarter in the U.S., better than that in Europe, again, teens. But looking forward, it's kind of hard to answer because looking now from July 1 on, July is kind of soft for us anyway. It is for everyone. it kind of gets, it's different year on year. I do think that this is a year where a lot of people are tired and traveling and taking off for the first time, so I think we're seeing some of that. But we'll see. Right now, we see strong, continued momentum in biopharma. You're specifically asking about biotech. We'll see. But, you know, I think most of our markets are still doing fine. I think you've seen our peers make the same kinds of statements, but But it's hard to really make a statement going into July and August. And, you know, in some of our areas, you know, especially like, you know, exosome, this is when they're the softest time of the year for them anyway. So things like that. But we'll know more in about a month or so. And we're not too concerned yet. I mean, things are, you know, kind of like we usually see about this time of year.

Aug 4, 2022 / receipt, needs a key / Jacob Johnson, other | earnings call 2022-08-04 | transcript c0de1e55-2b28-4bb8-a0b8-99e908a53e5f | chars 33288-34642 | segment 33

Encouragingly, some of the business practices we took for granted in the pre-pandemic world, including business travel, are slowly returning but remain below normal levels.

Aug 5, 2021 / receipt, needs a key / Chuck Cummins, CEO | earnings call 2021-08-05 | transcript b055d255-a6f1-464c-ba70-5b573dd5eecc | chars 4764-4936 | segment 4

Additionally, with our biopharma and academic customers now back to work and increasingly more receptive to in-person interaction, we are expecting the return of pre-pandemic activities, including corporate travel, to normalize as fiscal year 22 progresses.

Aug 5, 2021 / receipt, needs a key / Jim, other | earnings call 2021-08-05 | transcript b055d255-a6f1-464c-ba70-5b573dd5eecc | chars 28799-29056 | segment 29

Of course, you know, we talked about, you know, getting back in front of customers and business travel somewhat returning. You know, that's a pretty hefty number in itself in terms of a headwind year over year, assuming that that activity ramps back up.

Aug 5, 2021 / receipt, needs a key / Jim, CFO | earnings call 2021-08-05 | transcript b055d255-a6f1-464c-ba70-5b573dd5eecc | chars 49267-49520 | segment 50

The timing of hiring to support growth investments combined with COVID-restricted travel once again benefited our profitability.

May 6, 2021 / receipt, needs a key / Chuck Cometh, CEO | earnings call 2021-05-06 | transcript af53b595-59fa-4b98-a056-4a2edf467e05 | chars 3117-3245 | segment 3

Yeah, and so I guess that's how you define long term and short term, but I think the message I'm trying to convey here is that the fact we were able to hit 40% well ahead of schedule, some of it for our some reasons like travel and things like that that were unforeseen a couple years ago.

May 6, 2021 / receipt, needs a key / Chuck, CEO | earnings call 2021-05-06 | transcript af53b595-59fa-4b98-a056-4a2edf467e05 | chars 39298-39587 | segment 40

Also, our commercial teams have used time saved by not traveling to customer sites to aid our web support teams in uploading over 30,000 new images to what was already a best-in-class website.

Nov 5, 2020 / receipt, needs a key / Chuck Cometh, CEO | earnings call 2020-11-05 | transcript a79c3e78-6b7c-4331-9b34-a6f6cae039f1 | chars 5413-5605 | segment 5

Now, we've also really tuned our commercial force to much more inside sales and much more remote access to customers. No travel time, so no loss there, so that's probably an improvement.

Nov 5, 2020 / receipt, needs a key / Chuck, CEO | earnings call 2020-11-05 | transcript a79c3e78-6b7c-4331-9b34-a6f6cae039f1 | chars 27568-27754 | segment 27

filings
Advanced Manufacturing Technician | {"ats": "workday", "city": "Minneapolis", "state": "MN", "job_id": "/job/Minneapolis-MN/Advanced-Manufacturing-Technician_JR102071-1", "remote": false, "category":

company_statement / Sep 16, 2026 / receipt

Research Associate | {"ats": "workday", "city": "Minneapolis", "state": "MN", "job_id": "/job/Minneapolis-MN/Research-Associate_JR102099", "remote": false, "category": "other", "function": "retail", "

company_statement / Sep 16, 2026 / receipt

Supervisor, Kit Assembly | {"ats": "workday", "city": "Minneapolis", "state": "MN", "job_id": "/job/Minneapolis-MN/Supervisor--Kit-Assembly_JR102117", "remote": false, "category": "other", "function":

company_statement / Sep 16, 2026 / receipt

Supervisor, Shipping and Fulfillment

company_statement / Sep 16, 2026 / receipt

Supervisor, Shipping and Fulfillment | {"ats": "workday", "city": "Minneapolis", "state": "MN", "job_id": "/job/Minneapolis-MN/Supervisor--Shipping-and-Fulfillment_JR102140", "remote": false, "categor

company_statement / Sep 16, 2026 / receipt

Warehouse Picker Packer | {"ats": "workday", "city": "Minneapolis", "state": "MN", "job_id": "/job/Minneapolis-MN/Warehouse-Picker-Packer_JR102124", "remote": false, "category": "other", "function": "

company_statement / Sep 16, 2026 / receipt

Expanding position through disciplined strategic M&A

ir_statement / Sep 16, 2026 / receipt

Staff Accountant | {"ats": "workday", "city": "Newark", "state": "CA", "job_id": "/job/Newark-CA/Staff-Accountant_JR102132", "remote": false, "category": "other", "function": "finance", "location": "N

company_statement / Sep 15, 2026 / receipt

Reagent Sales Specialist (Texas) | {"ats": "workday", "city": null, "state": null, "job_id": "/job/US---Texas---Remote/Reagent-Sales-Specialist--Texas-_JR102081", "remote": true, "category": "sales_ex

company_statement / Sep 15, 2026 / receipt

Delivering industry leading operating margin

ir_statement / Sep 15, 2026 / receipt

Expanding position through disciplined strategic M&A

ir_statement / Sep 15, 2026 / receipt

Delivering industry leading operating margin

ir_statement / Sep 15, 2026 / receipt

executives
Chuck Comet CEO - receipt
Chuck Cometh CEO - receipt
Chuck Cummins CEO - receipt
David Claire VP, Investor Relations - receipt
David Eansor Senior Vice President - receipt
Jim Hippel CFO linkedin receipt
Kevin Gould Vice President - receipt
Kim Kelderman CEO - receipt
Matthew McManus President - receipt
N. David Eansor Senior Vice President - receipt
Robert Baumgartner Chairman of the Board - receipt
Steve Crouse President - receipt
familynone on file
upcoming
2026-11-04 earnings call scheduled ir
changes
2026-02-11 President, appointed sec_8k
2024-01-08 President, appointed sec_8k
2015-12-30 Vice President, appointed sec_8k
2015-03-20 Senior Vice President, appointed sec_8k
2014-07-08 Senior Vice President, appointed sec_8k
2012-11-05 Chairman of the Board, appointed sec_8k
mcp_package_hint
steadybase-$